41 citations as recorded by crossref.

1. Dual Surgical Setup May Improve Infection Control Rate of Debridement and Implant Retention Procedures for Periprosthetic Infections of the Hip and Knee A. Katakam et al. 10.1016/j.arth.2020.04.068
2. Comparative reinfection rate of one-stage versus two-stage revision in the management of periprosthetic joint infection following total hip arthroplasty: a meta-analysis Y. Qin et al. 10.1186/s12891-024-08199-y
3. Bacteriophage–antibiotic combinations against ciprofloxacin/ceftriaxone-resistant Escherichia coli in vitro and in an experimental Galleria mellonella model L. Wang et al. 10.1016/j.ijantimicag.2020.106200
4. Is Negative Pressure Wound Therapy with Instillation Suitable for the Treatment of Acute Periprosthetic Hip Joint Infection? N. Beckmann et al. 10.3390/jcm10153246
5. The outcomes of acute periprosthetic joint infection following unicompartmental knee replacement managed with early debridement, Antibiotics, and implant retention S. Asadollahi et al. 10.1016/j.knee.2023.12.001
6. New strontium-based coatings show activity against pathogenic bacteria in spine infection D. Ghezzi et al. 10.3389/fbioe.2024.1347811
7. Surgical strategies for management of infection following knee arthroplasty and arthroscopic procedures A. Alvand et al. 10.1016/j.mporth.2019.03.003
8. Proceedings of the United Kingdom Periprosthetic Joint Infection Meeting 2022: Combined and Arthroplasty Sessions N. Razii et al. 10.1016/j.arth.2023.06.039
9. An update on prosthetic joint infection for UK trainees S. Sabah et al. 10.1016/j.mpsur.2021.09.007
10. A comparsion study between debridement, antibiotics, and implant retention and two-stage revision total knee arthroplasty for the management of periprosthetic joint infection occurring within 12 weeks from index total knee arthroplasty Y. Zhang et al. 10.1186/s13018-022-03218-x
11. Irrigation and Debridement with Chronic Antibiotic Suppression Is as Effective as 2-Stage Exchange in Revision Total Knee Arthroplasty with Extensive Instrumentation J. Barry et al. 10.2106/JBJS.20.00240
12. Long-Term Patient-Related Quality of Life after Knee Periprosthetic Joint Infection N. Walter et al. 10.3390/jcm10050907
13. Tissue‐level cytokines in a rodent model of chronic implant‐associated infection N. Prince et al. 10.1002/jor.24940
14. Debridement, antibiotics and implant retention (DAIR): An effective treatment option for early prosthetic joint infections P. Tatarelli et al. 10.1016/j.jiac.2021.03.009
15. Polymicrobial Colonization of Prosthetic Joint Infections Treated With Open Wound Management M. Valenzuela et al. 10.1016/j.arth.2022.03.016
16. Early Debridement, antibiotics and implant retention (DAIR) in patients with suspected acute infection after hip or knee arthroplasty - safe, effective and without negative functional impact L. Barros et al. 10.7150/jbji.39168
17. Periprosthetic Joint Infection with Listeria monocytogenes T. Paziuk et al. 10.2106/JBJS.CC.19.00489
18. The Impact of a Dedicated Multidisciplinary Team Approach for Prosthetic Joint Infections of the Lower Limb J. Sires et al. 10.1007/s43465-023-00842-5
19. Antibiotic TMA (Therapeutic Methacrylic) Comonomers: Synergizing Mechanical Integrity with Infection Control in Bone Cement J. Singh et al. 10.1002/adfm.202406126
20. Fluorescent‐conjugated antibodies as rapid ex vivo markers for bacterial presence on orthopedic surgical explants and synovium: A pilot study D. Garcia et al. 10.1002/jor.24924
21. Debridement, antibiotics and implant retention (DAIR) for the management of knee prosthetic joint infection K. Vaz et al. 10.1016/j.knee.2020.08.011
22. Differing Microorganism Profile in Early and Late Prosthetic Joint Infections Following Primary Total Knee Arthroplasty — Implications for Empiric Antibiotic Treatment K. Kim et al. 10.1016/j.arth.2022.04.014
23. Staphylococcus aureus Prosthetic Joint Infection Is Prevented by a Fluorine‐ and Phosphorus‐Doped Nanostructured Ti–6Al–4V Alloy Loaded With Gentamicin and Vancomycin Á. Auñón et al. 10.1002/jor.24496
24. What Is the Most Effective Treatment for Periprosthetic Joint Infection After Total Joint Arthroplasty in Patients with Rheumatoid Arthritis? V. Desai et al. 10.2106/JBJS.RVW.23.00124
25. A review of current practices in periprosthetic joint infection debridement and revision arthroplasty H. Mian et al. 10.1186/s42836-022-00136-5
26. Current treatments for biofilm‐associated periprosthetic joint infection and new potential strategies A. Visperas et al. 10.1002/jor.25345
27. Revision knee replacement for prosthetic joint infection: Epidemiology, clinical outcomes and health-economic considerations S. Sabah et al. 10.1016/j.knee.2020.12.024
28. Higher 1-year risk of implant removal for culture-positive than for culture-negative DAIR patients following 359 primary hip or knee arthroplasties J. van Eck et al. 10.5194/jbji-7-143-2022
29. Estimating incidence rates of periprosthetic joint infection after hip and knee arthroplasty for osteoarthritis using linked registry and administrative health data X. Jin et al. 10.1302/0301-620X.104B9.BJJ-2022-0116.R1
30. In vitro and in vivo assessment of extended duration cathodic voltage‐controlled electrical stimulation for treatment of orthopedic implant‐associated infections K. Weeks et al. 10.1002/jor.25625
31. Management of ACL Reconstruction Complicated by MRSA Osteomyelitis Requiring a Gastrocnemius Perforator Flap I. Ifearulundu et al. 10.2106/JBJS.CC.23.00114
32. Antibiotic Therapy for Prosthetic Joint Infections: An Overview B. Le Vavasseur & V. Zeller 10.3390/antibiotics11040486
33. Controversies in orthopaedic oncology L. Jeys et al. 10.1302/0301-620X.106B5.BJJ-2023-1381
34. Synovial Glucose and Serum-to-Synovial Glucose Predict Failure After Acute Postoperative Infection in Total Knee Arthroplasty M. Sabater-Martos et al. 10.3390/jcm14082841
35. 2020 Frank Stinchfield Award: Identifying who will fail following irrigation and debridement for prosthetic joint infection N. Shohat et al. 10.1302/0301-620X.102B7.BJJ-2019-1628.R1
36. Current Clinical Methods for Detection of Peri-Prosthetic Joint Infection E. Berns et al. 10.1089/sur.2019.314
37. Risk Factors for Therapeutic Failure and One-Year Mortality in Patients with Intramedullary Nail-Associated Infection after Trochanteric and Subtrochanteric Hip Fracture Repair B. Pfang et al. 10.3390/antibiotics13050463
38. Improve Integration of In Vitro Biofilm Body of Knowledge to Support Clinical Breakthroughs in Surgical Site Infection S. Irwin et al. 10.5435/JAAOSGlobal-D-20-00217
39. Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms L. Wang et al. 10.3389/fmicb.2019.02522
40. How are Oral Antibiotics Being Used in Total Joint Arthroplasty? A Review of the Literature T. Weiner et al. 10.52965/001c.92287
41. Principles of mechanical and chemical debridement with implant retention D. Deckey et al. 10.1186/s42836-023-00170-x